These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 6924917)

  • 1. Polymorphism of BF, C2, and GLO in Japanese patients with insulin-dependent diabetes mellitus: confirmation of an increase of BF*FT.
    Tokunaga K; Omoto K; Juji T; Itoh T
    Hum Genet; 1982; 62(1):86-8. PubMed ID: 6924917
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA, complement C2, C4, properdin factor B and glyoxalase types in South Indian diabetics.
    Kirk RL; Ranford PR; Serjeantson SW; Thompson AR; Munirathnam Chetty SM; John L; Mohan V; Ramachandran A; Snehalatha C; Viswanathan M
    Diabetes Res Clin Pract; 1985 Mar; 1(1):41-7. PubMed ID: 3879724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human MHC class III (Bf, C2, C4) genes and GLO: their association with other HLA antigens and extended haplotypes in the Spanish population.
    Regueiro JR; Arnaiz-Villena A
    Tissue Antigens; 1988 Jan; 31(1):14-25. PubMed ID: 3341017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor B (Bf) and glyoxalase genes in insulin-dependent diabetes mellitus.
    Allannic H; Fauchet R; Gueguen M; Pheng Savath H; Dinh Knoi T; Genetet B
    Diabete Metab; 1985 Feb; 11(1):22-6. PubMed ID: 3856541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Properdin factor Bf polymorphism and glyoxase I allotypes in Graves' disease.
    Wenzel KW; Wenzel BE; Weise W
    Tissue Antigens; 1981 Feb; 17(2):247-8. PubMed ID: 6908967
    [No Abstract]   [Full Text] [Related]  

  • 6. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 2. Segregation analysis.
    Schunter F; Wernet P; Kömpf J; Bissbort S; Göhler F
    Hum Genet; 1978 Nov; 44(3):321-31. PubMed ID: 730170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of the linkage group GLO--Bf--HLA-B,C,A--PGM3. 1. Recombination frequencies.
    Kömpf J; Bissbort S; Göhler F; Schunter F; Wernet P
    Hum Genet; 1978 Nov; 44(3):313-9. PubMed ID: 730169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bf and C2 polymorphism in Japanese patients with juvenile onset diabetes mellitus: existence of a variant Bf allele.
    Tokunaga K; Omoto K; Maeda H; Juji T; Ishiba S; Maruyama H
    Tissue Antigens; 1981 Nov; 18(5):365-8. PubMed ID: 6920176
    [No Abstract]   [Full Text] [Related]  

  • 9. Properdin factor B (Bf) and glyoxalase in Graves' disease.
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Gueguen M; Knoi TD; Genetet B; Le Gall JY
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):57-61. PubMed ID: 6572032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red cell glyoxalase I polymorphism in Alsace, France: linkage of GLO with Bf.
    North ML; Amann I; Tongio MM; Hauptmann G; Klein J; Mayer S
    Hum Hered; 1981; 31(1):39-41. PubMed ID: 6910464
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetic susceptibility to diabetes mellitus: the distribution of properdin factor B (Bf) and glyoxalase (GLO) phenotypes.
    Kirk RL; Theophilus J; Whitehouse S; Court J; Zimmet P
    Diabetes; 1979 Oct; 28(10):949-51. PubMed ID: 478186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No evidence for linkage disequilibrium between Bf and GLO in African negroids.
    Bender K; Mauff G; Hitzeroth HW
    Hum Genet; 1977 Sep; 38(2):227-30. PubMed ID: 908570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism of properdin factor B in Japanese. Description of a rare variant and data of association with HLA and C2.
    Tokunaga K; Araki C; Juji T; Omoto K
    Hum Genet; 1982; 60(1):42-5. PubMed ID: 6918356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple sclerosis: immunogenetic analyses of sib-pair double case families. II. Studies on the association of multiple sclerosis with C2, C4, BF, C3, C6, and GLO polymorphisms.
    Schröder R; Zander H; Andreas A; Mauff G
    Immunobiology; 1983 Mar; 164(2):160-70. PubMed ID: 6552216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual "morphologic" variant of BF S.
    Raum D; Surgenor T; Awdeh Z; Marcus D; Blumenthal M; Yunis EJ; Alper CA
    Am J Hum Genet; 1984 Mar; 36(2):346-51. PubMed ID: 6585138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLO I and Bf phenotype distribution in a West German population sample.
    Mauff G; Wachauf P; Schaal KP; Pulverer G
    Hum Hered; 1978; 28(6):431-4. PubMed ID: 680704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA-linked complement polymorphisms (C2, BF) in psoriasis.
    Dewald G; Lange CE; Schmeel E; Kreysel HW
    Arch Dermatol Res; 1983; 275(5):301-4. PubMed ID: 6559061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of properdin factor B and glyoxalase I (further genetic markers) in Northern Ireland.
    Hamilton P; Middleton D
    Ulster Med J; 1988 Apr; 57(1):41-4. PubMed ID: 3166548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of HLA, factor B (Bf), complement C2 and C4 haplotypes in type 1 diabetic and control families from northern Sweden.
    Hägglöf B; Holmgren G; Holmlund G; Lindblom B; Olaisen B; Teisberg P
    Hum Hered; 1986; 36(4):201-12. PubMed ID: 3639057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic factors Bf and glyoxalase in Basedow's disease].
    Allannic H; Fauchet R; Lorcy Y; Phengsavath H; Guéguen M; Dinh KT; Le Gall JY; Genétet B
    Rev Med Interne; 1982 Jun; 3(2):129-32. PubMed ID: 6924395
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.